OBJECTIVE: To assess the value of Pathfinder (CompuCyte, Cambridge, Ma
ssachusetts, U.S.A.) in improving adequacy and accuracy of screening a
nd supporting quality control programs. STUDY DESIGN: The investigatio
ns were carried out on cervical cytologic smears only. Screening adequ
acy was assessed through the evaluation of percentage of slide coverag
e, percentage of overlapping and amount of elapsed time on smears scre
ened with or without the Pathfinder by junior (426 cases) and senior (
1,552 cases) screeners. Screening accuracy was investigated by compari
ng the performances of the same observer when reexamining, with the Pa
thfinder, a series of 1,051 cases already evaluated without the Pathfi
nder at least three months earlier. The review process was analyzed by
both monitoring the elapsed time for relocation of manually or electr
onically marked cells (824 fields in 80 smears) and by comparing diagn
ostic discrepancies after the review of two series (74+74 cases) of ra
ndomly selected negative cases screened with or without Pathfinder. RE
SULTS: Pathfinder-assisted screening increased the number of cases wit
h optimal slide coverage (greater than or equal to 90% of screenable a
rea) and optimal overlaying (between 15% and 20%) by both junior (P<.0
0001 and P<.00001) and senior (P<.00001 and P<.0003) screeners. It als
o improved screening accuracy by decreasing the number of cases ''unsa
tisfactory for evaluation'' (P<.00001) (as a consequence of better cov
erage and overlapping) and the number of diagnostic discrepancies dete
cted after review (P=.05). During the latter process, the time elapsed
for relocation of electronically marked fields, as compared to manual
ly marked ones, was greatly reduced (1 hour, 25 minutes saved for revi
sion of 40 smears). CONCLUSION: In these preliminary studies, the Path
finder was a useful tool for both education and diagnosis (screening a
nd review in a cytology laboratory.